Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,132.40
(
0.00%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.76
(
-0.88%
)
Bitcoin
73,936.84
(
-0.01%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ThomasS

Send PM Follow Ignore
Followers 12
Posts 2277
Boards Moderated 0
Alias Born 05/05/2005

ThomasS

Re: DewDiligence post# 103569

Tuesday, 09/07/2010 12:08:36 AM

Tuesday, September 07, 2010 12:08:36 AM

Post# of 257253
MNTA: If your proposed explanation is, indeed, fact then it suggests that Teva knew they would have great difficulty defending Copaxone. It further suggests that the Court also saw this. Bullish for MNTA.
A less plausible explanation is simple oversight/incompetence/arrogance. Arrogance: Perhaps Teva never expected a generic.

"If we don't succeed, we run the risk of failure."
-Dan Quayle

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now